BusinessNeurofibromatosis Therapeutics Pipeline is Driven by Unmet Medical Needs: P&S Market ResearchBy Nasdaq OMXJan 30, 2018, 11:30 AM UTC
BusinessAcne Vulgaris Therapeutics Pipeline Has Moved Towards the Development of Biologicals and Peptides: P&S Market ResearchBy Nasdaq OMXJan 30, 2018, 10:45 AM UTC
BusinessHemophilia Therapeutics Pipeline to Witness Major Collaborations in The Future: P&S Market ResearchBy Nasdaq OMXAug 25, 2017, 8:52 AM UTC
